Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: NRXN1 microdeletions are associated with an increased genetic risk for various neuropsychiatric disorders, with diverse breakpoints complicating research, diagnosis, and treatment. This study aims to investigate the deletion rate and penetrance of NRXN1 microdeletions across different clinical phenotypes through meta-analysis while exploring their relationship with epilepsy and summarizing the characteristics of NRXN1 biallelic variations.
Methods: For meta-analysis, a systematic review of published studies was conducted to calculate NRXN1 microdeletion rates and penetrance across different disorders, with comparisons to control groups. For systematic review, data from 401 cases across 57 studies were analyzed to compare microdeletion characteristics in patients with and without epilepsy, alongside a review of NRXN1 biallelic variation clinical features.
Results: NRXN1 microdeletion carriers had a 3.20-fold higher disease risk compared to noncarriers. The deletion rate was elevated in patients with autism, schizophrenia, and Tourette syndrome relative to controls. Additionally, NRXN1 microdeletions were more prevalent in epilepsy patients with comorbidities than in those with epilepsy alone. Among epilepsy patients, 81.3% had comorbidities. Deletions involving exons 1-6 were more frequent in patients with epilepsy, of whom 71.42% were diagnosed with genetic generalized epilepsy (GGE). Among those with NRXN1 biallelic variations, 53.84% had epilepsy, and all experienced generalized seizures.
Significance: Understanding genotype-phenotype associations in NRXN1 microdeletion-related diseases is critical for early diagnosis and management. Our study shows that NRXN1 microdeletions have been associated with various neuropsychiatric disorders and exhibit incomplete penetrance. In epilepsy, patients with NRXN1 microdeletions are associated with mental comorbidities and generalized seizure types, particularly involving exon 1-6 deletions, and are common in patients with GGE.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/epi.18337 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical phenotypic spectrum of NRXN1 microdeletions and their association with epilepsy: A systematic review and meta-analysis.
Epilepsia
June 2025
Department of Neurology, The First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, National Key Clinical Department and Key Discipline of Neurology, Guangzhou, China.
Objective: NRXN1 microdeletions are associated with an increased genetic risk for various neuropsychiatric disorders, with diverse breakpoints complicating research, diagnosis, and treatment. This study aims to investigate the deletion rate and penetrance of NRXN1 microdeletions across different clinical phenotypes through meta-analysis while exploring their relationship with epilepsy and summarizing the characteristics of NRXN1 biallelic variations.
Methods: For meta-analysis, a systematic review of published studies was conducted to calculate NRXN1 microdeletion rates and penetrance across different disorders, with comparisons to control groups.
[Prenatal diagnosis of partial deletion of NRXN1 gene with combined CNV-seq and qPCR assays].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
November 2022
Prenatal Diagnosis Center, Urumqi Maternal and Child Health Care Hospital, Urumqi, Xinjiang 830000, China.
Article Synopsis
- The study focused on the genetic diagnosis of 7 fetuses with specific deletions in the NRXN1 gene located at 2p16.3, using low-depth copy number variation sequencing (CNV-seq).
- All 7 fetuses exhibited confirmed deletions through quantitative real-time PCR (qPCR), with details on the size and origin of the deletions documented, including some inherited from parents and some being de novo.
- After genetic counseling, pregnancy outcomes varied: one couple opted for abortion, one case is still ongoing, and five children were born healthy with no reported mental abnormalities.
NRXN1 Deletion in Two Twins' Genotype and Phenotype: A Clinical Case and Literature Review.
Children (Basel)
May 2022
Unit of Pediatrics and Pediatric Emergency, AOU "Policlinico", PO "San Marco", University of Catania, 95100 Catania, Italy.
In the literature, deletions in the 2p16.3 region of the neurexin gene (NRXN1) are associated with cognitive impairment, and other neuropsychiatric disorders, such as schizophrenia, autism, and Pitt-Hopkins-like syndrome 2. In this paper, we present twins with deletion 2p16.
View Article and Find Full Text PDFHomozygous exonic and intragenic NRXN1 deletion presenting as either West syndrome or autism spectrum disorder in two siblings.
Clin Neurol Neurosurg
March 2022
Department of Medical Genetics, İstanbul Medipol University, İstanbul, Turkey.
Neurexins (NRXNs) are cell-adhesion molecules that play critical roles in establishing and maintaining synaptic connections. Humans have three NRXN genes (NRXN1, NRXN2, NRXN3) and heterozygous intragenic microdeletions involving NRXN1 have been associated with autism spectrum disorder, attention deficit hyperactivity disorder, intellectual disability, seizures, schizophrenia, and bipolar disorder. Bi-allelic loss in NRXN1 produces a recessive and severe phenotype.
View Article and Find Full Text PDFAn increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder.
J Cell Mol Med
March 2021
Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Autism spectrum disorder (ASD) is characterized by a complex polygenic background, but with the unique feature of a subset of cases (~15%-30%) presenting a rare large-effect variant. However, clinical interpretation in these cases is often complicated by incomplete penetrance, variable expressivity and different neurodevelopmental trajectories. NRXN1 intragenic deletions represent the prototype of such ASD-associated susceptibility variants.
View Article and Find Full Text PDF